[go: up one dir, main page]

EP1328151A4 - Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer - Google Patents

Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer

Info

Publication number
EP1328151A4
EP1328151A4 EP00953630A EP00953630A EP1328151A4 EP 1328151 A4 EP1328151 A4 EP 1328151A4 EP 00953630 A EP00953630 A EP 00953630A EP 00953630 A EP00953630 A EP 00953630A EP 1328151 A4 EP1328151 A4 EP 1328151A4
Authority
EP
European Patent Office
Prior art keywords
hyde
cancer
proteins
induction
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00953630A
Other languages
German (de)
English (en)
Other versions
EP1328151A2 (fr
Inventor
Mitchell S Steiner
Chiang Wang
Augustinus Rinaldy
Rema Menon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/499,817 external-priority patent/US7043009B1/en
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of EP1328151A2 publication Critical patent/EP1328151A2/fr
Publication of EP1328151A4 publication Critical patent/EP1328151A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00953630A 1999-04-29 2000-05-01 Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer Withdrawn EP1328151A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US30245799A 1999-04-29 1999-04-29
US13160799P 1999-04-29 1999-04-29
US131607P 1999-04-29
US302457 1999-04-29
US09/499,817 US7043009B1 (en) 2000-02-08 2000-02-08 Providing customer data to an automatic call distribution system agent
US499817 2000-02-08
PCT/US2000/011456 WO2000071564A2 (fr) 1999-04-29 2000-05-01 Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer

Publications (2)

Publication Number Publication Date
EP1328151A2 EP1328151A2 (fr) 2003-07-23
EP1328151A4 true EP1328151A4 (fr) 2004-06-16

Family

ID=27384176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00953630A Withdrawn EP1328151A4 (fr) 1999-04-29 2000-05-01 Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer

Country Status (5)

Country Link
EP (1) EP1328151A4 (fr)
JP (1) JP2003529321A (fr)
AU (1) AU769889B2 (fr)
CA (1) CA2371828A1 (fr)
WO (1) WO2000071564A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
JP7716984B2 (ja) * 2019-03-05 2025-08-01 ダウ グローバル テクノロジーズ エルエルシー カスパーゼ活性の誘導
CN113106082B (zh) * 2021-05-27 2022-11-04 云南师范大学 动物粪便宏基因组来源的丙氨酸消旋酶及其制备和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001059127A2 (fr) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Enzymes metabolisant les medicaments
WO2001072962A2 (fr) * 2000-03-24 2001-10-04 Fahri Saatcioglu Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022695A2 (fr) * 1995-12-20 1997-06-26 Fondation Jean Dausset-Ceph Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001059127A2 (fr) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Enzymes metabolisant les medicaments
WO2001072962A2 (fr) * 2000-03-24 2001-10-04 Fahri Saatcioglu Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 *
DATABASE EMBL [online] EBI; 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10829 fis, clone NT2RP4001138", XP002276044, retrieved from EMBL Database accession no. AK001691 *
JOHNSON M.I.; HAMDY F.C.: "Apoptosis regulating genes in prostate cancer (Review)", ONCOLOGY REPORTS, vol. 5, no. 3, May 1998 (1998-05-01), pages 553 - 557, XP009028911 *
RINALDY A R ET AL: "Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.", GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY. JAPAN MAY 2000, vol. 27 Suppl 2, May 2000 (2000-05-01), pages 215 - 222, XP009028708, ISSN: 0385-0684 *
STEINER M S ET AL: "GROWTH INHIBITION OF PROSTATE CANCER BY AN ADENOVIRUS EXPRESSING A NOVEL TUMOR SUPPRESSOR GENE, PHYDE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 16, 15 August 2000 (2000-08-15), pages 4419 - 4425, XP001076638, ISSN: 0008-5472 *
ZHANG X ET AL: "APOPTOSIS INDUCTION IN PROSTATE CANCER CELLS BY A NOVEL GENE PRODUCT, PHYDE, INVOLVES CASPASE-3", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 42, 20 September 2001 (2001-09-20), pages 5982 - 5990, XP008003138, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
AU6604600A (en) 2000-12-12
WO2000071564A3 (fr) 2003-05-01
AU769889B2 (en) 2004-02-05
CA2371828A1 (fr) 2000-11-30
EP1328151A2 (fr) 2003-07-23
WO2000071564A2 (fr) 2000-11-30
WO2000071564A8 (fr) 2001-10-04
JP2003529321A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
DE69943292D1 (de) Verfahren zur Amplifikation und Sequenzierung von Nucleinsäuren und zur Herstellung von Nucleinsäuren mit verminderter thermodynamischer Stabilität
DE60032226D1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE69928683D1 (de) Verfahren zur amplifikation und zur sequenzierung von nukleinsäuren
DE59912604D1 (de) Verfahren zur isolierung und aufreinigung von nucleinsäuren
DE69942659D1 (de) Verfahren zur Herstellung und Verwendung von durchsichtigen hitzebeständigen Harzen
DE69736598D1 (de) Ribonukleaseresistente rna präparation und seine verwendung
DE69837041D1 (de) Verfahren und mikroorganism zur herstellung von purin-nukleosiden durch fermentation
ATE499153T1 (de) Verfahren zur vorhydrolyse von biomasse
DE60002793D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE19980848D2 (de) Verfahren zur Detektion von Mikroorganismen in Produkten
DE69929310D1 (de) Tumorassoziierte antigenderivate der mage-familie, nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
DE10084502T1 (de) Verfahren zur Reinigung von Nukleinsäure mit Siliciumcarbid
DE69132843D1 (de) Identifizierung von Nukleinsäuren in Proben
DE60132937D1 (de) Verfahren zur Herstellung von Benzimidazol-2-yl -Chinolinonderivaten
DE60144083D1 (de) Verfahren zur Herstellung von basischen Aminosäuren
PT88425A (pt) Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins
DE60012549D1 (de) Verfahren zur isolierung von nukleinsäuren und kit
DE60107987D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE60044694D1 (de) Verfahren zur Bestimmung von Cholesterin und Sensor dafür
DE60125747D1 (de) Verfahren zur herstellung von 2-halobenzoesäuren
DE60033825D1 (de) Detektion von unterschieden in nukleinsäuren durch inhibierung spontaner dna verzweigungsmigration
DE50207915D1 (de) Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
DE59915087D1 (de) Verfahren zur kontrolle von schadorganismen in kulturen von bt-baumwolle
DE50010521D1 (de) Verfahren zur kalten herstellung von perlglänzenden tensidzubereitungen
DE69909181D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011112

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/861 B

Ipc: 7A 61K 31/7052 B

Ipc: 7C 12Q 1/70 B

Ipc: 7G 01N 33/574 B

Ipc: 7C 07K 16/30 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 B

Ipc: 7A 01K 67/027 B

Ipc: 7C 12P 21/00 B

Ipc: 7A 61P 35/00 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 07K 16/00 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 07H 21/00 B

Ipc: 7C 12N 15/62 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040504

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411